Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Animal & Veterinary

FDA Announces Phibro Animal Health Requests Voluntary Withdraw of Application for Medicated Poultry Feed

August 22, 2013

The U.S. Food and Drug Administration is announcing that Phibro Animal Health Corporation has requested that FDA withdraw approval of New Animal Drug Application (NADA) 098-371 for the use of nicarbazin, penicillin, and roxarsone in three-way, combination drug Type C medicated feeds for broiler chickens, and NADA 098-374 for use of nicarbazin and penicillin in two-way, combination drug Type C medicated feeds for broiler chickens. These drugs have been approved for use in animal feed for over 40 years.

Although Phibro Animal Health Corporation withdrew its approved NADA voluntarily because these products are no longer being manufactured or marketed, the decision to remove these antibiotic-containing feeds from the market for production purposes supports FDA’s voluntary strategy for judicious use of antibiotics in food-producing animals.


Contact FDA

240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

7519 Standish Place, HFV-1

Rockville, MD 20855

Page Last Updated: 01/05/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English